AbbVie Inc.
ABBVPabrik ObatTutup
286.72-0.0%Leverage nepi ka 1000xDagang ABBV
Naon anu diumumkeun
Diumumkeun dina 2026-07-31, 89 dinten ka tukang.
Perkiraan dibandingkeun hasil
| Perkiraan | Nyata | Kejutan | |
|---|---|---|---|
| Panghasilan | 16.8B | 17.0B+10.2% taun ka taun | +1.1% |
| Laba bersih | 6.4B | 3.6B+285.2% taun ka taun | -43.4% |
| Kauntungan per saham | 3.61 | 3.65+22.9% taun ka taun | +1.1% |
Babandingan taun ka taun nganggo kuartal anu sarua taun ka tukang (2025-07-31), lain kuartal saacanna.
ABBV didagangkeun di dieu kalayan leverage nepi ka 1000x. Dina 1000x, gerakan 0.10% ngalawan anjeun bakal ngabéjaan sadaya margin. Ieu can ngitung fee, funding, jeung maintenance margin, anu sadayana bakal ngagancangkeun liquidation. Harga liquidation nu sabenerna nyaéta anu ditembongkeun dina kaca pesenan.
Di dieu anjeun tiasa nahan posisi ngaliwatan waktos pangumuman
ABBV dihargaan di dieu 24 jam sadinten sarta teu eureun nalika pasar AS tutup. Dina bursa AS, warta anu sarua ngan bakal katingal salaku gap dina bubuka salajengna.
Ekspektasi pasar
Pikeun kuartal anu réngsé dina 2026-09-30.
Dibandingkeun jeung kuartal anu sarua taun kamari (2025-10-31): EPS +100.9%panghasilan +9.8%
Ieu ramalan ti analis pihak katilu. CoinUnited.io teu nyusun sareng teu milih analis anu diasupkeun.
Asal panghasilan
- SKYRIZI34.3%5.5B
- RINVOQ15.7%2.5B
- Other Products6.9%1.1B
- Vraylar6.7%1.1B
- Botox Therapeutic6.5%1.0B
- VENCLEXTA4.8%771.0M
Kuartal panganyarna anu dilaporkeun (2026-06-30). 10 bagian nu leuwih leutik teu ditembongkeun.
Rekam Jejak
Laporan salajengna dipiharep 2026-10-30. Ngalaporkeun quarterly.
Ngaleuwihan estimasi dina 7 ti 8 kuartal panungtungan. Bédana nu lumrah nyaéta +0.07 per saham.
Sabaraha gedéna gerakan nu saenyana
±6.8%
Gerakan median dina dua sési sabudeureun laporan, tina 8 hasil panungtungan. Dina dua poé biasa, gerakanana 1.1%.
2026-07-31-3.37%
2024-10-30Gerakan salila dua sesi di sabudeureun unggal laporan2026-07-31
Ngaleuwihan atawa kurang, tuluy naék atawa turun
| Naék | Turun | |
|---|---|---|
| Ngaleuwihan | 4 | 3 |
| Kurang | 1 | 0 |
Diitung tina 8 hasil. Ieu nu geus kajadian, lain nu bakal kajadian.
Perkiraan analis pikeun 12 bulan ka hareup
Rentang waktu ieu béda ti bagian séjén dina kaca ieu: ieu pandangan 12 bulan, sanés pergerakan dua dinten di sabudeureun laporan kauangan.
| Lembaga | Sasaran | Tanggal | Sumber |
|---|---|---|---|
| Goldman Sachs | 294.00 | 2026-10-23 | TheFly |
| Barclays | 325.00 | 2026-10-21 | TheFly |
| Cantor Fitzgerald | 290.00 | 2026-10-08 | StreetInsider |
| Morgan Stanley | 310.00 | 2026-10-07 | TheFly |
| Scotiabank | 320.00 | 2026-10-06 | TheFly |
| HSBC | 315.00 | 2026-09-10 | TheFly |
| Piper Sandler | 303.00 | 2026-08-20 | TheFly |
| Wells Fargo | 300.00 | 2026-08-17 | TheFly |
| Wolfe Research | 300.00 | 2026-08-13 | TheFly |
| Guggenheim | 288.00 | 2026-08-04 | TheFly |
| Canaccord Genuity | 290.00 | 2026-08-03 | StreetInsider |
| UBS | 260.00 | 2026-07-13 | TheFly |
| BMO Capital | 300.00 | 2026-07-13 | TheFly |
| RBC Capital | 280.00 | 2026-07-10 | StreetInsider |
| Evercore ISI | 235.00 | 2026-05-15 | TheFly |
Data ti 15 lembaga anu ngumumkeun target harga dina 180 dinten katukang, nganggo perkiraan panganyarna unggal lembaga. Target harga ditangtukeun ku lembaga éta; CoinUnited.io teu nyusun sareng teu ngadukung éta.
Hasil Laporan
| Dilaporkeun | EPS estimasi | EPS aktual | Kejutan | Kejutan Panghasilan |
|---|---|---|---|---|
| 2026-07-31 | 3.61 | 3.65 | +1.1% | +1.1% |
| 2026-04-29 | 2.59 | 2.65 | +2.3% | +1.9% |
| 2026-02-04 | 2.65 | 2.71 | +2.3% | +1.2% |
| 2025-10-31 | 1.77 | 1.86 | +5.1% | +1.2% |
| 2025-07-31 | 2.88 | 2.97 | +3.1% | +2.6% |
| 2025-04-25 | 2.38 | 2.46 | +3.4% | +3.2% |
| 2025-01-31 | 2.98 | 2.16 | -27.5% | +1.8% |
| 2024-10-30 | 2.92 | 3 | +2.7% | +1.2% |
| 2024-07-25 | 2.57 | 2.65 | +3.1% | +3.1% |
| 2024-04-26 | 2.26 | 2.31 | +2.2% | +3.2% |
| 2024-02-02 | 2.76 | 2.79 | +1.1% | +10.2% |
| 2023-10-27 | 2.86 | 2.95 | +3.1% | +1.9% |
Ogé ngalaporkeun dina dua minggu ieu di Pabrik Obat
AMGN 
AZN 
BMY 
GILD 
GSK 
LLY 4 deui di Pabrik Obat
Riwayat EPS pikeun ABBV ti 2011-03-31 nepi ka 2026-07-31, 55 laporan.Riwayat réaksi nyangkup 8 hasil panungtungan, sarua jerona jeung data harga harian dasar kami.